Not medical advice. I am a software engineer, not a physician. This page documents my own protocol and the research I read while building it. Talk to a qualified clinician before changing your supplementation, diet or any treatment. Lab reference ranges quoted here vary by laboratory and by individual.
Affiliate disclosure: the iHerb links on this page carry a referral code and pay me a commission if you buy. It does not change your price, and I do not link anything I do not use myself.
Diindolylmethane (DIM) is a bioactive compound formed from the digestion of indole-3-carbinol (I3C), which is found in cruciferous vegetables (broccoli, cauliflower, cabbage, Brussels sprouts). While you would need to eat approximately 500g of raw broccoli daily to achieve therapeutic DIM levels, supplementation provides a concentrated, reliable dose. DIM has emerged as a critical component of hormonal optimization protocols because it fundamentally redirects how the body processes estrogen.
This is particularly important for men using testosterone-supporting supplements (ashwagandha, tribulus, zinc). As testosterone levels increase, aromatase enzyme activity converts a portion to estradiol. DIM does not block aromatase directly — instead, it shifts the downstream metabolism of estrogen toward the protective 2-hydroxyestrone (2-OHE1) pathway and away from the proliferative 16α-hydroxyestrone (16α-OHE1) pathway. This ratio is the marker most of the research is built around; the association with cancer risk is observational, not an established causal effect of supplementation.
DIM's hormonal effects center on estrogen metabolism modulation:
DIM vs. I3C: Indole-3-carbinol (I3C) is the dietary precursor, but it is unstable in the acidic stomach environment and can form undesirable condensation products. DIM is the stable, active metabolite. Supplementing DIM directly bypasses the unpredictable I3C conversion step and delivers a consistent dose of the active compound.
Do not start DIM if you take tamoxifen without speaking to your oncologist. A 2025 safety analysis found DIM reduced metabolism of tamoxifen and of its active metabolite endoxifen, which could lower the drug's effectiveness. Also speak to a clinician before use if you are pregnant or breastfeeding, or have a hormone-sensitive condition.
| Parameter | Recommendation |
|---|---|
| Product | SM Nutrition DIM |
| Dose | 400 mg per day (1 capsule) |
| Timing | With dinner |
| With food | Yes — fat improves DIM absorption |
| Cycling | No cycling protocol is established; long-term safety at this dose has not been studied in trials |
| Study | Finding | PMID |
|---|---|---|
| Dalessandri et al., 2004 | DIM supplementation (108 mg/day) significantly increased urinary 2-OHE1 levels and the 2:16α-OHE1 ratio in postmenopausal women, confirming the favorable shift in estrogen metabolism toward the protective pathway | 21911367 |
| Le et al., 2003 | DIM inhibited proliferation and induced apoptosis in human breast cancer cells (MCF-7) through cell cycle arrest at G1 and downregulation of CDK6. Anti-proliferative effects were dose-dependent and independent of estrogen receptor status | 16251887 |
| Thomson et al., 2017 | Systematic review of DIM and I3C in breast cancer prevention: consistent evidence for increased 2:16α estrogen metabolite ratio, with emerging evidence for anti-proliferative, pro-apoptotic, and anti-angiogenic effects in hormone-responsive cancers | 28944486 |
Estradiol is the primary monitoring target, especially for men using testosterone-supporting supplements alongside DIM.
| Test | Why It Matters | Link |
|---|---|---|
| Estradiol (E2) | DIM shifts estrogen metabolism without directly lowering estradiol. Track to ensure estrogen stays in optimal range (20-35 pg/mL for men) | Lab Tests |
SM Nutrition — DIM, 400 mg, 90 Capsules
Price: $29.01
Buy on iHerb →
A July 2025 study published in Menopause examined DIM's effects on estrogen profiles of postmenopausal women receiving transdermal estradiol therapy. Results showed that DIM significantly altered 6 of 10 estrogen metabolites measured (including estrone, estriol, 2-OHE1, 2-OHE2, 4-OHE2, and 16-OHE1), leading to lower total estrogen exposure and a favorable shift in the 2-OH:16α-OH ratio. SHBG also increased significantly. A 2024 study in premenopausal women confirmed sustained shifts in urinary estrogen metabolism with DIM supplementation. Importantly, safety analysis revealed a potential interaction with tamoxifen: DIM reduced metabolism of the parent compound and its active metabolite endoxifen, raising concerns for breast cancer patients on this medication. This finding reinforces the recommendation to disclose DIM use to oncologists.